Excipients: Povidone K-30, Lactose, Corn starch, Microcrystalline Cellulose, Colloidal silica dioxide, Talc, Magnesium stearate, Hydroxyproylmethylcellulose, , Red aluminium lake 4R, Polyethyleneglycol 6000, Propyleneglycol, Sodium saccharine
Treatment effects based on data obtained from treatment completers A frequently used method to estimate the effect in randomized trials is through restricting the analysis set to comprising only data from patients who continue the randomized treatment until the scheduled end-of-treatment visit (i.e., treatment completers)
Systemic injection (lower abdomen or upper thigh) supplements it
Purity by a named analytical method is not the same as a complete safety profile
It exhibits an IC 50 of approximately 1 M for NNMT inhibition 4 , with favorable pharmacokinetic properties